- Companies
- Alan
Alan Revenue, Valuation, Funding & Investors
Alan is valued at $6.4B as of June 2026, a 7.2x multiple on its last reported $890M revenue.
Last Alan valuation
$6.4B
Series G · Jun 2026
Last Alan funding round
$559M
Series G · Jun 2026
Alan revenue
$890M
Series G · Jun 2026
Key investors in Alan
Index Ventures
Temasek
Teachers’ Venture Growth
Coatue
Partech
Ribbit Capital
About Alan
Alan delivers digital health insurance services from Paris, France. The company supplies supplemental health coverage to businesses including telemedicine consultations, online claims processing, and mental health support. Alan serves small and medium enterprises across France with tailored group policies. Founded in 2016, it partners with medical networks for rapid reimbursements and preventive care programs.
Founded
2016
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Revenue
$890M (Jun 2026)
Valuation
$6.4B (Jun 2026)
Sectors
Alan Valuation
Alan is currently valued at $6.4B, based on its Series G in June 2026.
The $559M round was led by Prosus, with participation from Dara Holdings, Index Ventures and Teachers’ Venture Growth.
Alan's valuation has grown 3.8x from $1.7B at its Series D in April 2021 to $6.4B in June 2026, across 5 priced rounds.
Alan valuation by funding round
Revenue multiple| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Jun 2026 | Series G | $6.4B | 7.2x |
| Mar 2026 | Undisclosed stage | $5.9B | 6.4x |
| Sep 2024 | Series F | $4.5B | 8.6x |
| May 2022 | Series E | $2.9B | - |
| Apr 2021 | Series D | $1.7B | 14.5x |
Alan Revenue
Alan's latest recorded revenue is $890M, as of its Series G in June 2026. At a $6.4B valuation, that implies a 7.2x revenue multiple.
Revenue grew from $115M in April 2021 to $890M in June 2026, while the revenue multiple moved from 14.5x to 7.2x.
Alan revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Jun 2026 | $890M | $6.4B | 7.2x | Series G |
| Mar 2026 | $915M | $5.9B | 6.4x | Undisclosed stage |
| Sep 2024 | $518M | $4.5B | 8.6x | Series F |
| Apr 2021 | $115M | $1.7B | 14.5x | Series D |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
Alan Funding History
Alan has raised a total of $1.4B across 9 funding rounds, plus 1 secondary share sale.
Alan's first fundraising round was a $13M seed round in October 2016. The most recent completed round was a $559M Series G in June 2026.
Alan funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Jun 2026 | Secondary | Prosus (lead); Dara Holdings; Index Ventures; Teachers’ Venture Growth | - | - | - |
| Jun 2026 | Series G | Prosus (lead); Dara Holdings; Index Ventures; Teachers’ Venture Growth | $559M | $6.4B | French healthtech startup Alan raised €480 million ($550 million) in a Series G funding round, valuing the company at €5.5 billion ($6.3 billion). The round was led by Dutch investment giant Prosus, which contributed €400 million ($460 million) in primary and secondary equity, alongside existing investors Teachers' Venture Growth (TVG) and Index Ventures, and new investor Dara Holdings. The deal supports Alan's international expansion across France, Spain, Belgium, and Canada while accelerating the development of its artificial intelligence-led prevention insurance products. In Q1 2026, Alan surpassed €800 million in annual recurring revenue, representing 53% year-on-year growth. This round boosts Alan's valuation by at least €500 million in under three months since its previous €100 million raise at a €5 billion valuation. The company has now raised over €1.2 billion in total funding across nine rounds. The transaction remains subject to regulatory approvals from French financial authorities. |
| Mar 2026 | Undisclosed stage | Index Ventures (lead); SH Capital; Greenoaks; Kylian Mbappé; KAAF Investments; Tobias Lütke; Mike Katchen; Belfius Bank; Antoine Griezmann | $118M | $5.9B | - |
| Sep 2024 | Series F | Belfius Bank (lead); Temasek; Teachers’ Venture Growth; Lakestar; Coatue | $193M | $4.5B | Alan is a French health insurance startup founded in 2016 that offers AI-powered, user-friendly health services including doctor chats, prescription orders, insurance sign-up, plan management, claims submission, and reimbursement processing through a mobile app or web portal. The company covers over 650,000 members and operates across France and Belgium, with Belgium as its second-largest market. In September 2024, Alan raised $193 million in its Series F funding round led by Belgian bank Belfius, valuing the company at $4.5 billion post-money. The round included participation from existing investors Ontario Teachers' Pension Plan (via Teachers' Venture Growth), Temasek, Coatue, and Lakestar, plus prominent entrepreneurs from France and internationally. At the time of this round, Alan expected to hit €450 million in annual recurring revenue for the year. The investment included a multi-faceted partnership with Belfius beyond the capital injection. The bank agreed to provide Alan's health insurance products to its 7,000 employees and distribute them to its corporate and institutional clients, representing millions of employees in Belgium. This distribution partnership was designed to significantly expand Alan's customer base in its second-largest market. The company has demonstrated strong growth trajectory since joining the unicorn club in 2021, raising approximately €750 million cumulatively since inception. However, Alan remained unprofitable during this period, reporting net losses of €61 million in 2023 and €56 million in 2024, though losses as a percentage of revenue had improved significantly year-over-year. |
| May 2022 | Series E | Teachers’ Venture Growth (lead); Temasek; Dragoneer; Index Ventures; Origins Fund; Ribbit Capital; Teampact ventures; Lakestar; Coatue; Exor Ventures | $197M | $2.9B | - |
| Apr 2021 | Series D | Coatue (lead); Temasek; Ambel; Dragoneer; Index Ventures; Ribbit Capital; H14; Exor Ventures | $222M | $1.7B | Alan is a French insurtech startup founded in 2016 that provides health insurance and a healthcare super-app, offering transparent pricing, personalized care, proactive health services, and integrations like APIs and payroll for companies from startups to enterprises. By April 2021, it covered around 155,000 to 160,000 members across France, Belgium, and Spain, with clients including WeWork, Deliveroo, Just Eat, Vitaliance, and Big Mamma. On April 19, 2021, Alan raised a $220 million (€185 million) Series D funding round led by Coatue, with participation from Dragoneer Investment Group, Exor Ventures, and existing investors Index Ventures, Ribbit Capital, and Temasek Holdings, achieving a post-money valuation of $1.67 billion (€1.4 billion). The round matched the investors and lead specified, following a prior $54 million raise in April 2020 from Index and Temasek. Funds were earmarked for international expansion, hiring 400 more staff to reach about 750 employees, product development including healthcare services, and scaling to 1 million members in Europe by 2023. At the time of the round, Alan reported over €100 million ($120 million) in annualized revenue, reflecting strong growth after doubling its member base since the previous round and ending 2020 profitably despite regulatory capital needs for insurance compliance. The company had sufficient cash runway for 12-18 months post-round. Alan's model disrupts traditional health insurance with a mobile-first app combining coverage checks, claims filing, prevention programs for mental health and wellness, and concierge services, positioning it as a comprehensive health partner in a post-pandemic world. |
| Apr 2020 | Series C | Temasek (lead); Index Ventures | $55M | - | Alan is a France-based digital health insurer founded in 2016, offering online health insurance plans for individuals and companies, underwriting its own policies as the first new independent health insurer in France in three decades. It also provides telemedicine appointments and an app for locating medical professionals. The company closed a €50 million ($54.4 million) Series C round on April 20, 2020, led by Singapore's Temasek Holdings with participation from existing investor Index Ventures, bringing total funding to €125 million ($141 million). Prior rounds included a €40 million Series B in February 2019 led by Index Ventures, a $28.4 million Series A in 2018 also led by Index Ventures, and a $13 million seed in 2016 led by CNP Assurances. The funds will support opening two new European offices, improving health insurance coverage, digitizing corporate healthcare offerings, developing a leading app for instant health info, and international expansion. |
| Feb 2019 | Series B | Index Ventures (lead); DST Global | $46M | - | Alan is a Paris-based health insurance technology company founded in 2016 as the first new independent health insurer licensed in France since 1986. The company offers digital-first health insurance services to employers and individuals, allowing customers to choose doctors, obtain quotes, and receive reimbursements through its technology platform. In February 2019, Alan closed a €40 million Series B funding round led by Index Ventures and partners of DST Global. This followed the company's €23 million Series A round in April 2018, bringing total capital raised to over €75 million in its first three years of operation. At the time of the Series B announcement, Alan had grown its insured customer base to 27,000 and reported €22 million in revenue for 2018, serving companies including My Little Paris, Le Slip Français, Ledger, and Converteo. The company's team expanded from 14 to 64 employees during 2018. Alan stated it was very close to breaking even and planned to use the Series B funding to accelerate payments processing, improve quote response times, enhance customer service, launch new services, and expand its user base and team. |
| Apr 2018 | Series A | Index Ventures (lead); CNP Assurances; Portage Ventures; Partech; Xavier Niel | $28M | - | - |
| Oct 2016 | Seed | CNP Assurances; Partech; Power Financial; AGORANOV | $13M | - | - |
Who has invested in Alan?
29 investors have backed Alan across its funding rounds, including Index Ventures, Temasek, Teachers’ Venture Growth, Coatue, Partech and Ribbit Capital.
Lead investors include Prosus, Index Ventures, Belfius Bank, Teachers’ Venture Growth, Coatue and 1 other investor.
Alan Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 8 | Lead | Apr 2018 | ||
| 4 | Lead | Apr 2020 | ||
| 4 | Lead | May 2022 | ||
| 3 | Lead | Apr 2021 | ||
| 2 | Participant | Jun 2026 | ||
| 2 | Participant | Apr 2021 | ||
| 2 | Participant | Oct 2016 | ||
| 2 | Participant | Oct 2016 | ||
| 2 | Lead | Jun 2026 | ||
| 2 | Participant | Apr 2021 | ||
| 2 | Lead | Sep 2024 | ||
| 2 | Participant | May 2022 | ||
| 2 | Participant | Apr 2021 | ||
This data is available for Pro users. Sign up to see all 29 Alan investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by Alan
Alan has acquired 4 companies to date.
Last acquisition by Alan was on September 2nd 2026. Alan acquired Tanél Health for undisclosed valuation.
Latest Acquisitions by Alan
| Description | Tanél Health is a software provider for pharmacies and payers, offering an integrated operating system with inventory management and sales monitoring features. Headquartered in the United States, the platform connects pharmacies, suppliers, insurers, and patients to streamline drug distribution, compliance, and reimbursement processes. Tanél Health serves independent pharmacies and health systems across North America. | ARO develops health prevention technologies. | - | Jour is a Brooklyn, New York-headquartered mobile app that delivers guided journaling sequences for teens and adults addressing mental health and mindfulness. Launched in January 2019, the platform offers audio sessions and prompted questions to foster reflective writing and build a personal archive of insights. |
| HQ Country | - | - | ||
| HQ City | Dakar | - | - | New York City, NY |
| Deal Date | 2 Sep 2026 | 8 Mar 2026 | 27 Jun 2024 | 21 Sep 2021 |
| Valuation | undisclosed | undisclosed | $2.7B | $20M |
| EV/Revenue | ||||
| EV/EBITDA | ||||
This data is available for Pro users. Sign up to see all Alan acquisitions and their M&A valuation multiples. Start Free Trial | ||||
Alan Competitors
Alan competitors include listed companies like PB Fintech, Accelerant, Oscar Health and Lemonade, and private ones like wefox and Root Insurance.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $708M | $58M | $8.5B | 10.1x | ||
| Private | $850M | - | $4.6B | 5.4x | ||
| Publicly listed | $880M | ($1.2B) | $4.3B | 3.7x | ||
| Publicly listed | $12B | ($391M) | $9.9B | 0.4x | ||
| Publicly listed | $738M | ($146M) | $3.8B | 3.5x | ||
| Private | $43M | $132M | $3.6B | - |
Alan Public Comps
Alan is still privately-owned, but its public comps include PB Fintech, Accelerant, Lemonade, Rasan, Oscar Health, Slide Insurance Holdings, Clover Health, Ethos Insurance, ZhongAn and Baige Online.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $708M | $58M | 11.7x | 10.1x | 143.3x | 101.3x | |||
| $880M | ($1.2B) | 4.5x | 3.7x | (3.3x) | 12.9x | |||
| $738M | ($146M) | 5.1x | 3.5x | (25.9x) | (55.1x) | |||
| $174M | $73M | 16.1x | 11.0x | 38.6x | 25.9x | |||
| $12B | ($391M) | 0.5x | 0.4x | (15.9x) | 12.8x | |||
| $1.2B | $605M | 1.5x | 1.0x | 2.8x | 2.7x | |||
| $1.9B | ($84M) | 1.1x | 0.8x | (25.8x) | 34.1x | |||
| $388M | $79M | 5.6x | 3.4x | 27.2x | 19.2x | |||
This data is available for Pro users. Sign up to see all Alan competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Alan
| When was Alan founded? | Alan was founded in 2016. |
| Where is Alan headquartered? | Alan is headquartered in Paris, France. |
| Is Alan publicly listed? | No, Alan is a private, VC-backed company. |
| What is Alan's valuation? | Alan was last valued at $6.4B in its Series G in June 2026. |
| How much funding has Alan raised? | Alan has raised $1.4B across 9 funding rounds. |
| What was Alan's last funding round? | Alan's last funding round was a $559M Series G in June 2026, led by Prosus. |
| Who are Alan's investors? | Alan's investors include Index Ventures, Temasek, Teachers’ Venture Growth, Coatue, Dara Holdings, Dragoneer, CNP Assurances, Partech, Prosus, Ribbit Capital and 19 others. |
| What is Alan's revenue? | Alan's latest recorded revenue is $890M (June 2026). |
| What is Alan's revenue multiple? | Alan's latest valuation implies a 7.2x revenue multiple ($6.4B valuation on $890M of revenue). |
| Which companies are comparable to Alan? | Companies comparable to Alan include PB Fintech, wefox, Accelerant, Oscar Health, Lemonade and Root Insurance. |
| How many companies has Alan acquired? | Alan has acquired 4 companies, including Tanél Health, ARO, Wave.ai and Jour. |
| What was the largest acquisition by Alan? | The $2.7B acquisition of Wave.ai in June 2024 is the largest acquisition Alan has made to date. |
See companies similar to Alan
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




